AlphaFold predicted structure
IL3 · P08700

Mean pLDDT
83.3/ 100
Confident
152 residues
Confidence breakdown
- Very high(≥ 90)59%
- Confident(70–90)14%
- Low(50–70)26%
- Very low(< 50)1%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
interleukin 3
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
COVID-19 research
Unknownatopic eczema
asthma
psoriasis
myocardial infarction
neoplasm
Sepsis
dermatitis
systemic lupus erythematosus
Alzheimer disease
inflammatory bowel disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Interleukin-3
Cytokine secreted predominantly by activated T-lymphocytes as well as mast cells and osteoblastic cells that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells (PubMed:2556442). Also stimulates mature basophils, eosinophils, and monocytes to become functionally activated (PubMed:10779277, PubMed:32889153). In addition, plays an important role in neural cell proliferation and survival (PubMed:23226269). Participates as well in bone homeostasis and inhibits osteoclast differentiation by preventing NF-kappa-B nuclear translocation and activation (PubMed:12816992). Mechanistically, exerts its biological effects through a receptor composed of IL3RA subunit and a signal transducing subunit IL3RB (PubMed:29374162). Receptor stimulation results in the rapid activation of JAK2 kinase activity leading to STAT5-mediated transcriptional program (By similarity). Alternatively, contributes to cell survival under oxidative stress in non-hematopoietic systems by activating pathways mediated by PI3K/AKT and ERK (PubMed:27862234)
IL3 · P08700

Mean pLDDT
83.3/ 100
Confident
152 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0